| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.091 | 0.05 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.068 | 0.3 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.043 | 0.4 |